We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
EGlobe | BIT:EGB | Italy | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.01 | 0.74% | 1.37 | 1.36 | 1.45 | 1.42 | 1.33 | 1.33 | 36,000 | 16:40:00 |
MILANO (MF-NW)--Mediobanca Securities conferma rating outperform su Recordati (-0,14%) dopo che la svizzera Novartis ha registrato conti trimestrali leggermente oltre il consensus e alzato la guidance di Ebit 2023. Gli esperti, comunque, vedono uno spazio limitato per una lettura di questi numeri in riferimento ai fondamentali dell'azienda italiana visto il mix differente. In ogni caso, l'aggiornamento fornito da Novartis conferma i solidi trend organici nell'industria del Pharma.
fus
marco.fusi@mfnewswires.it
(END) Dow Jones Newswires
October 24, 2023 06:17 ET (10:17 GMT)
Copyright (c) 2023 MF-Dow Jones News Srl.
1 Year EGlobe Chart |
1 Month EGlobe Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions